Sorafenib
98%
- Product Code: 103493
Alias:
Sorafenib p-toluenesulfonate; Sorafenib; Sorafenib; Sora+E51 Rani; NEXAVAR;
CAS:
284461-73-0
| Molecular Weight: | 464.83 g./mol | Molecular Formula: | C₂₁H₁₆ClF₃N₄O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | 202-204°C | Boiling Point: | 523.3ºC |
| Density: | 1.454 g/cm3 | Storage Condition: | room temperature |
Product Description:
Sorafenib is primarily used as a targeted therapy in the treatment of advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and differentiated thyroid carcinoma. It works by inhibiting multiple kinases involved in tumor growth and angiogenesis, thereby slowing the progression of these cancers. In liver cancer, it is often prescribed when surgical options are not viable. For kidney cancer, it is used when the disease has spread or become resistant to other treatments. In thyroid cancer, it is employed for cases that are no longer responsive to radioactive iodine therapy. The drug is administered orally, allowing for convenient outpatient treatment, and is typically taken twice daily. Regular monitoring is required to manage potential side effects, such as hypertension, skin reactions, and gastrointestinal issues.
Product Specification:
| Test | Specification |
|---|---|
| Purity (%) | 97.5-100 |
| Appearance | White To Gray Powder |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | ฿500.00 |
+
-
|
| 5.000 | 10-20 days | ฿1,820.00 |
+
-
|
| 25.000 | 10-20 days | ฿6,030.00 |
+
-
|
| 100.000 | 10-20 days | ฿18,350.00 |
+
-
|
Sorafenib
Sorafenib is primarily used as a targeted therapy in the treatment of advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and differentiated thyroid carcinoma. It works by inhibiting multiple kinases involved in tumor growth and angiogenesis, thereby slowing the progression of these cancers. In liver cancer, it is often prescribed when surgical options are not viable. For kidney cancer, it is used when the disease has spread or become resistant to other treatments. In thyroid cancer, it is employed for cases that are no longer responsive to radioactive iodine therapy. The drug is administered orally, allowing for convenient outpatient treatment, and is typically taken twice daily. Regular monitoring is required to manage potential side effects, such as hypertension, skin reactions, and gastrointestinal issues.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :